Epsilon Healthcare

Epsilon Healthcare PEG

The PEG Ratio (Price/Earnings-to-Growth) of Epsilon Healthcare (EPN.AX) as of Nov 3, 2026 is -0.12.

PEG

-0.12

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Epsilon Healthcare is 2025 -0.12 . PEG Ratio (Price/Earnings-to-Growth) of Epsilon Healthcare was 2024 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Epsilon Healthcare Stock analysis

What does Epsilon Healthcare do? Epsilon Healthcare Ltd generates revenue through the manufacture and distribution of hydroponics equipment, materials, and nutrients, targeting commercial growers and hobbyists. The company also develops and delivers medical cannabis, operating a manufacturing facility in the Southern Hemisphere and providing advisory services for medicinal cannabis. Its subsidiaries, including Tetra Health clinic and Medimar Platform, offer end-to-end e-commerce solutions for nutraceuticals and cannabis, while Canna Clinics Pty Ltd and THC Pharma Pty Ltd deliver medical cannabis products. The firm's business segments focus on hydroponics and medicinal cannabis, serving both B2B and B2C markets through its branded platforms and subsidiaries. The company's products include hydroponics equipment, materials, nutrients, and medical cannabis, sold via its Medimar Platform e-commerce solution and physical locations like Tetra Health clinic. Subsidiaries such as Dragon Vision Limited and Metra Holdings Pty Ltd support operations, while Canndeo Pty Ltd and Canna Clinics Pty Ltd specialize in cannabis cultivation and delivery. The firm's advisory services for medicinal cannabis cater to healthcare providers and clinics, with the Tetra Health clinic serving as a direct sales channel for medical cannabis products. Epsilon Healthcare Ltd's revenue streams are derived from hydroponics equipment sales, medical cannabis distribution, and advisory services. The Medimar Platform serves as a primary channel for e-commerce transactions, while Tetra Health clinic and Canna Clinics Pty Ltd provide physical retail and medical services. The company's Southern Hemisphere manufacturing facility ensures supply chain control for medical cannabis, and its subsidiaries like THC Pharma Pty Ltd handle product development and delivery. The business model integrates manufacturing, distribution, and digital commerce to serve both commercial and medical cannabis markets. Epsilon Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Epsilon Healthcare stock

PEG Ratio (Price/Earnings-to-Growth) of Epsilon Healthcare is -0.12 in 2025.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Epsilon Healthcare since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Epsilon Healthcare with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Epsilon Healthcare

All Key Metrics — Epsilon Healthcare